Notice Information
Notice Title
Radiopharmacy Managed Services
Notice Description
Guy's and St Thoma's NHS Foundation Trust (Contracting Authority) is undertaking this procurement to appoint a Service Provider to enter into an MSA for the provision of Radiopharmacy manufacturing services, delivered through a Hub and Spoke operating model. The Trust's existing Radiopharmacy Unit, located at Guy's Hospital (the "Spoke"), provides highly specialised diagnostic, therapeutic and research support to Nuclear Medicine and other clinical services within the GSTT, Royal Brompton and Harefield Hospitals. Radiopharmacy services are integral to a wide range of patient pathways, including diagnostic imaging, cancer diagnosis and treatment, clinical trials and research activity. Demand for radiopharmaceuticals is expected to continue to increase in line with advances in imaging, personalised medicine and oncology pathways. The Contracting Authority's existing facilities are constrained by physical space, ageing infrastructure and regulatory limitations, which restrict capacity and prevent expansion. The Contracting Authority has therefore determined that an MSA represents the most appropriate mechanism to deliver a new, off site, GMP compliant Radiopharmacy Hub, while retaining a reduced on site Spoke function during the initial phase of service delivery. This approach will enable increased production capacity, improved resilience of supply, enhanced regulatory compliance and long-term sustainability. The Trust intends to implement the Hub and Spoke model through a phased delivery approach. Upon contract award the appointed Service Provider will be responsible for the design and fit-out of the Hub during the first year of the MSA/Contract. During the second year, the Service Provider shall obtain all relevant regulatory licenses with the commencement of services initiating Phase 1 of the Hub starting in the third year. During this phase, the existing Spoke at Guy's Hospital will continue to provide defined on site radiopharmacy functions to support clinical continuity, resilience and safe transition to the new operating model. These timings are estimates and Tenderers are required to provide a detailed mobilisation as part of their response to Questionnaire 3: Technical and Social Value Questionnaire). At the sole discretion of the Contracting Authority, Phase 2 may be initiated, to transfer additional manufacturing activities from the Spoke to the Hub once the Hub is fully operational, stable and licensed. Phase 2 is not guaranteed and will only be implemented following an initial period from service commencement. Any decision to proceed with Phase 2 will be subject to performance, regulatory and operational readiness criteria as set out in Document 2: Managed Service Agreement). Further detail on the phasing of Services and associated TUPE arrangements is provided in Section 6.6 and the Document 2: Managed Service Agreement). The MSA and procurement documentation have been structured to accommodate this potential future phase in a transparent and compliant manner. This ITT therefore seeks Tenders from suitably qualified and experienced organisations capable of designing, establishing, licensing and operating the Radiopharmacy Hub and working in partnership with the Contracting Authority over the life of the Contract. The scope of Services, phased delivery arrangements and contractual requirements are set out within the ITT Pack, including Document 2: Managed Service Agreement (MSA).
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-06ef52
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/082551-2026
- Current Stage
- Tender
- All Stages
- Tender
Procurement Classification
- Notice Type
- UK4 - Tender Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Open
- Procurement Method Details
- Competitive flexible procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33000000 - Medical equipments, pharmaceuticals and personal care products
33151000 - Radiotherapy devices and supplies
33151400 - Radiotherapy supplies
33697000 - Medical preparations excluding dental consumables
85121200 - Medical specialist services
85145000 - Services provided by medical laboratories
85149000 - Pharmacy services
Notice Value(s)
- Tender Value
- £85,000,000 £10M-£100M
- Lots Value
- £85,000,000 £10M-£100M
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 1 Sep 2026Today
- Submission Deadline
- 29 Sep 20264 weeks to go
- Future Notice Date
- Not specified
- Award Date
- Not specified
- Contract Period
- 1 Jul 2027 - 30 Jun 2039 Over 5 years
- Recurrence
- Not specified
Notice Status
- Tender Status
- Active
- Lots Status
- Active
- Awards Status
- Not Specified
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- Guy's and St Thomas' NHS Foundation Trust
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- LONDON
- Postcode
- SE1 9RT
- Postcode Area
- South East London
- Country
- England
-
- Major Region (ITL 1)
- TLI London
- Basic Region (ITL 2)
- TLI4 Inner London - East
- Small Region (ITL 3)
- TLI44 Lewisham and Southwark
- Delivery Location
- TLI London, TLI4 Inner London - East
-
- Local Authority
- Southwark
- Electoral Ward
- London Bridge & West Bermondsey
- Westminster Constituency
- Bermondsey and Old Southwark
Further Information
Notice Documents
-
https://www.find-tender.service.gov.uk/Notice/082551-2026
1st September 2026 - Tender notice on Find a Tender
Open Contracting Data Standard (OCDS)
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.